Logo image of LCTX

LINEAGE CELL THERAPEUTICS IN (LCTX) Stock Earnings & Estimates

NYSEARCA:LCTX - US53566P1093 - Common Stock

1.22 USD
+0.05 (+4.27%)
Last: 9/2/2025, 8:15:24 PM
1.2091 USD
-0.01 (-0.89%)
After Hours: 9/2/2025, 8:15:24 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
LCTX revenue by date.LCTX revenue by date.
14.7M
238.71%
8.945M
-39.15%
9.499M
6.19%
8.699M
-8.42%
24.253M
178.80%
18.737M
-22.74%
58.77M
213.66%
90.845M
54.58%
161.47M
77.74%
281.6M
74.40%
407.68M
44.77%
EBITDA
YoY % growth
LCTX ebitda by date.LCTX ebitda by date.
-21.79M
54.92%
-24.041M
-10.33%
-20.869M
13.19%
-27.183M
-30.26%
-15.555M
42.78%
-26.01M
-67.21%
-25.342M
2.57%
-21.471M
15.27%
-16.85M
21.52%
-18.207M
-8.05%
-19.737M
-8.40%
EBIT
YoY % growth
LCTX ebit by date.LCTX ebit by date.
-22.52M
54.24%
-24.733M
-9.83%
-21.478M
13.16%
-34.841M
-62.22%
-19.131M
45.09%
-26.767M
-39.91%
7.367M
127.52%
33.362M
352.86%
121.8M
265.09%
239.53M
96.66%
397.25M
65.85%
Operating Margin
LCTX operating margin by date.LCTX operating margin by date.
-153.20%-276.50%-226.11%-400.52%-78.88%-142.86%12.54%36.72%75.43%85.06%97.44%
EPS
YoY % growth
LCTX eps by date.LCTX eps by date.
-0.15
42.31%
-0.13
13.33%
-0.10
23.08%
-0.15
-50.08%
-0.07
53.40%
-0.09
-26.40%
0.06
166.92%
0.13
117.24%
0.44
239.29%
0.74
69.01%
1.05
43.02%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.03
-31.12%
-0.03
-176.83%
-0.01
74.50%
-0.02
74.50%
-0.03
-16.69%
-0.04
-28.96%
-0.03
-500.00%
-0.03
-71.43%
-0.03
16.67%
-0.04
-14.29%
Revenue
Q2Q % growth
2.419M
-35.99%
2.157M
-24.79%
9.305M
519.51%
5.097M
84.34%
1.265M
-47.71%
1.265M
-41.35%
1.117M
-88.00%
1.117M
-78.09%
1.117M
-11.70%
1.117M
-11.70%
EBITDA
Q2Q % growth
-5.957M
-76.13%
-5.998M
-33.25%
-7.65M
-20.64%
-7.762M
-68.56%
-7.844M
-31.68%
-7.925M
-32.14%
-7.997M
-4.53%
-8.16M
-5.12%
-8.16M
-4.03%
-8.16M
-2.96%
EBIT
Q2Q % growth
-6.914M
-80.06%
-7.581M
-48.36%
-609.195K
90.63%
-5.311M
-7.51%
-9.728M
-40.70%
-10.604M
-39.88%
-8.654M
-1,320.51%
-8.827M
-66.20%
-9M
7.48%
-9.169M
13.54%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
-0.07
-133.33%
-0.03-0.04-152.86%
Q1 2025
Q2Q % growth
-0.02
50.00%
-0.030.0121.57%
Q4 2024
Q2Q % growth
-0.01
66.67%
-0.010.00-14.40%
Q3 2024
Q2Q % growth
-0.02
50.00%
-0.040.0254.25%
Q2 2024
Q2Q % growth
-0.03 -0.050.0236.06%
Q1 2024
Q2Q % growth
-0.04
-33.33%
-0.040.00-2.31%
Q4 2023
Q2Q % growth
-0.03 -0.040.0131.38%
Q3 2023
Q2Q % growth
-0.04 -0.040.008.50%
Q2 2023
Q2Q % growth
-0.03
25.00%
-0.050.0233.59%
Q1 2023
Q2Q % growth
-0.03
25.00%
-0.040.0123.27%
Q4 2022
Q2Q % growth
-0.03
82.35%
-0.040.0120.81%
Q3 2022
Q2Q % growth
-0.04
20.00%
-0.040.00-12.04%
Q2 2022
Q2Q % growth
-0.04
-33.33%
-0.040.008.50%
Q1 2022
Q2Q % growth
-0.04
-300.00%
-0.03-0.01-15.34%
Q4 2021
Q2Q % growth
-0.17
-1,800.00%
-0.05-0.12-257.12%
Q3 2021
Q2Q % growth
-0.05 -0.050.00-2.12%
Q2 2021
Q2Q % growth
-0.03
25.00%
-0.040.0119.79%
Q1 2021
Q2Q % growth
-0.01
83.33%
-0.040.0371.99%
Q4 2020
Q2Q % growth
0.01
133.33%
-0.050.06121.31%
Q3 2020
Q2Q % growth
-0.05
58.33%
-0.050.00-8.93%
Q2 2020
Q2Q % growth
-0.04
80.00%
-0.040.001.96%
Q1 2020
Q2Q % growth
-0.06
-120.00%
-0.05-0.01-22.55%
Q4 2019
Q2Q % growth
-0.03 -0.050.0243.44%
Q3 2019
Q2Q % growth
-0.12 -0.05-0.07-120.60%
Q2 2019
Q2Q % growth
-0.20 -0.05-0.15-277.07%
Q1 2019
Q2Q % growth
0.30 -0.060.36574.38%
LCTX Yearly EPS VS EstimatesLCTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.5 -0.5 1
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
2.765M
96.38%
1.502M1.263M84.09%
Q1 2025
Q2Q % growth
1.502M
4.02%
1.904M-402K-21.11%
Q4 2024
Q2Q % growth
2.868M
37.36%
1.654M1.214M73.40%
Q3 2024
Q2Q % growth
3.779M
203.29%
1.054M2.725M258.54%
Q2 2024
Q2Q % growth
1.408M
-56.34%
988.635K419.365K42.42%
Q1 2024
Q2Q % growth
1.444M
-39.48%
1.387M57K4.11%
Q4 2023
Q2Q % growth
2.088M
8.75%
1.336M752K56.29%
Q3 2023
Q2Q % growth
1.246M
-58.47%
2.646M-1.4M-52.91%
Q2 2023
Q2Q % growth
3.225M
-29.12%
2.241M984K43.91%
Q1 2023
Q2Q % growth
2.386M
-54.47%
2.049M337K16.45%
Q4 2022
Q2Q % growth
1.92M
64.10%
2.617M-697K-26.63%
Q3 2022
Q2Q % growth
3M
32.16%
3.975M-975K-24.53%
Q2 2022
Q2Q % growth
4.55M
792.16%
3.758M792K21.08%
Q1 2022
Q2Q % growth
5.24M
1,243.59%
7.47M-2.23M-29.85%
Q4 2021
Q2Q % growth
1.17M
225.00%
856.8K313.2K36.55%
Q3 2021
Q2Q % growth
2.27M
298.25%
521.22K1.749M335.52%
Q2 2021
Q2Q % growth
510K
30.77%
418.2K91.8K21.95%
Q1 2021
Q2Q % growth
390K
-23.53%
357K33K9.24%
Q4 2020
Q2Q % growth
360K
-70.97%
939.93K-579.93K-61.70%
Q3 2020
Q2Q % growth
570K 438.6K131.4K29.96%
Q2 2020
Q2Q % growth
390K
-50.00%
568.905K-178.905K-31.45%
Q1 2020
Q2Q % growth
510K
-45.16%
656.88K-146.88K-22.36%
Q4 2019
Q2Q % growth
1.24M 1.051M189K17.98%
Q3 2019
Q2Q % growth
570K 824.497K-254.497K-30.87%
Q2 2019
Q2Q % growth
780K 1.008M-228K-22.62%
Q1 2019
Q2Q % growth
930K 760.512K169.488K22.29%
LCTX Yearly Revenue VS EstimatesLCTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M 400M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-5.85% 29.89% -66.58% -66.58%
Revenue25.6% 74.41% 27.33% 5.29%